Filing Details
- Accession Number:
- 0001209191-14-073666
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-08 16:45:05
- Reporting Period:
- 2014-12-08
- Filing Date:
- 2014-12-08
- Accepted Time:
- 2014-12-08 16:45:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1372299 | Histogenics Corp | HSGX | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184421 | Kevin Rakin | C/O Histogenics Corporation 830 Winter Street, 3Rd Floor Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-08 | 9,667 | $0.00 | 22,985 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-12-08 | 5,871 | $0.00 | 28,747 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2014-12-08 | 242 | $0.76 | 28,989 | No | 4 | X | Direct | |
Common Stock | Disposition | 2014-12-08 | 17 | $11.00 | 28,972 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-12-08 | 6,742 | $11.00 | 35,714 | No | 4 | P | Direct | |
Common Stock | Disposition | 2014-12-08 | 89 | $0.00 | 35,625 | No | 4 | J | Direct | |
Common Stock | Acquisiton | 2014-12-08 | 6,444 | $0.00 | 42,069 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2014-12-08 | 3,914 | $0.00 | 45,983 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2014-12-08 | 4,495 | $11.00 | 50,478 | No | 4 | P | Indirect | See Footnote |
Common Stock | Disposition | 2014-12-08 | 58 | $0.00 | 50,420 | No | 4 | J | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct | |
No | 4 | P | Direct | |
No | 4 | J | Direct | |
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
No | 4 | J | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2014-12-08 | 9,667 | $0.00 | 9,667 | $0.00 |
Common Stock | Series A-1 Preferred Stock | Disposition | 2014-12-08 | 5,871 | $0.00 | 5,871 | $0.00 |
Common Stock | Common Stock Warrant (Right to Buy) | Disposition | 2014-12-08 | 242 | $0.00 | 225 | $0.76 |
Common Stock | Series A Preferred Stock | Disposition | 2014-12-08 | 6,444 | $0.00 | 6,444 | $0.00 |
Common Stock | Series A-1 Preferred Stock | Disposition | 2014-12-08 | 3,914 | $0.00 | 3,914 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | X | Direct | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Reflects a 10.804-to-1 reverse stock split effected on November 14, 2014.
- All outstanding shares of the Issuer's preferred stock converted on a 1:1 basis into shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration and including accrued dividends. These shares have no expiration date.
- The Common Stock Warrant was automatically net exercised, immediately prior to the closing of the Issuer's initial public offering. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 17 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 225 shares. The expiration date of the warrant is upon the consummation of the Issuer's initial public offering or a liquidity event (as described in such warrant).
- The reportable securities are owned by the Kevin L. Rakin Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
- These shares of Common Stock were transferred to a strategic partner of the Issuer to satisfy the Reporting Person's contractual obligations under certain agreements between the Issuer, the Reporting Person, certain of the Issuer's other stockholders, and such strategic partner.